Bioregenx annual free cash flow
2023
2024
2025
Bioregenx Free Cash Flow (FCF) History (BRGX)
Bioregenx reported $29,915 in free cash flow for fiscal 2025, an increase of $543,453 from the previous fiscal year, with a free cash flow margin of 1.61%.
View full Bioregenx company overviewBioregenx free cash flow by year
| Fiscal year | Period ended | Free cash flow | Change | Growth | FCF margin |
|---|---|---|---|---|---|
| 2025 | 2025-12-31 | $29,915 | $543,453 | — | +1.61% |
| 2024 | 2024-12-31 | −$513,538 | $1.0M | — | −21.95% |
| 2023 | 2023-12-31 | −$1.5M | — | — | −44.41% |
Bioregenx quarterly free cash flow
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
| Fiscal quarter | Period ended | Free cash flow | Change | YoY growth | FCF margin |
|---|---|---|---|---|---|
| Q4 2025 | 2025-12-31 | $66,579 | $77,940 | — | +17.26% |
| Q3 2025 | 2025-09-30 | −$77,564 | −$46,368 | — | −15.28% |
| Q2 2025 | 2025-06-30 | $3,205 | $180,546 | — | +0.72% |
| Q1 2025 | 2025-03-31 | $37,695 | $331,335 | — | +7.32% |
| Q4 2024 | 2024-12-31 | −$11,361 | $234,265 | — | −2.47% |
| Q3 2024 | 2024-09-30 | −$31,196 | $252,268 | — | −5.23% |
| Q2 2024 | 2024-06-30 | −$177,341 | $471,820 | — | −24.16% |
| Q1 2024 | 2024-03-31 | −$293,640 | $43,152 | — | −53.43% |
| Q4 2023 | 2023-12-31 | −$245,626 | — | — | −36.23% |
| Q3 2023 | 2023-09-30 | −$283,464 | — | — | −35.68% |
| Q2 2023 | 2023-06-30 | −$649,161 | — | — | −75.20% |
| Q1 2023 | 2023-03-31 | −$336,792 | — | — | −31.31% |
Bioregenx free cash flow growth trends
Bioregenx's latest reported quarter, Q4 2025, generated $66,579 in free cash flow, an increase of $77,940 year over year.
About the metric
What free cash flow means
Free cash flow is the cash a company generates from operations after capital expenditures. Positive FCF can fund dividends, buybacks, debt repayment, or reinvestment; negative FCF means capital spending exceeded operating cash flow for that period.
Calculation and source
How free cash flow is calculated
TickerStat calculates free cash flow as SEC-reported operating cash flow minus capital expenditures. FCF margin equals free cash flow divided by revenue. Fiscal periods can differ from calendar years, so the tables include exact period-end dates.
Review Bioregenx filings at SEC.gov ↗